Key Points
- FibroScan provides two numbers—CAP and stiffness—that give insight into liver fat and potential scarring.
- Always ask your provider how your scores fit with blood tests, metabolic markers, and imaging history.
- Researchers see potential for FibroScan in tracking fatty liver changes, but interpretation remains debated and should not be used in isolation.
Why Fatty Liver Needs More Than a Blood Test
Fatty liver disease—now often called Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) and formerly known as NAFLD—affects millions worldwide.
Blood tests can reveal enzyme changes such as ALT or AST, but they rarely tell the full story. That is why imaging plays a central role. Two noninvasive tools—FibroScan (transient elastography, VCTE) and standard ultrasound—are widely used. They require no anesthesia or biopsy needles and provide real-time insights into fat accumulation and liver stiffness.
FibroScan in Plain Language
FibroScan uses a small probe over the right ribcage to send painless vibrations into the liver. It measures how fast those signals travel, similar to tapping a wall to check its density.
It produces two key values:
- CAP (Controlled Attenuation Parameter): Estimates the degree of fat in the liver.
- Liver Stiffness (kPa): Suggests whether scar tissue (fibrosis) may be present.
Together, these markers help clinicians judge if fatty liver is mild, progressing, or accompanied by fibrosis.
Ultrasound: The First Look
Ultrasound is often the first imaging ordered when fatty liver is suspected. Fatty tissue appears brighter (“hyperechoic”) on the screen.
- Advantages: Widely available, inexpensive, and can also reveal gallstones or bile duct changes.
- Limits: It is less precise for fibrosis staging and can miss early or subtle fat changes. Sensitivity drops in mild steatosis and in people with higher body weight.
Reading Your CAP Score
CAP values are reported in decibels per meter (dB/m). Higher numbers usually suggest more fat. Approximate ranges reported in research:
- < 238 dB/m: No steatosis detected.
- 238–259 dB/m: Mild fat (≥~10% of liver cells affected).
- 260–290 dB/m: Moderate fat.
- ≥ 291 dB/m: Severe fat accumulation.
Important caveat: Cutoffs can vary depending on probe type (M vs XL), body mass index, and population studied. CAP should always be read alongside waist circumference, triglycerides, and blood sugar levels—not in isolation.
Reading Your Liver Stiffness Score
Liver stiffness reflects fibrosis risk, reported in kilopascals (kPa). Reference bands often used in clinics:
- < ~6 kPa: Low likelihood of significant fibrosis.
- 6–9 kPa: Possible early fibrosis.
- 9–12 kPa: Suggestive of moderate fibrosis.
- > ~12–15 kPa: Higher likelihood of advanced fibrosis or cirrhosis.
Context matters. These thresholds are approximate and may differ by disease cause (MASLD, viral hepatitis, alcohol-related liver disease), body weight, diabetes status, and even recent meals. Suspicious scores often require confirmation with additional tests such as FIB-4, MRI elastography (MRE), or biopsy.
Why Scores Can Fluctuate
Patients sometimes worry when scores change between visits. Variability is common. Factors include:
- Fasting vs. fed state: Eating a meal can increase stiffness readings; CAP may decrease after meals. Most centers recommend fasting at least 3 hours beforehand.
- Inflammation or congestion: Conditions such as hepatitis flare-ups or heart failure can temporarily affect stiffness.
- Probe placement and body habitus: Obesity, ascites, or small rib spaces can limit accuracy; an XL probe may be needed.
- Recent activity: Strenuous exercise just before the test may shift values slightly.
How FibroScan Compares to Biopsy
Liver biopsy remains the gold standard for microscopic details, but it is invasive and carries risks. FibroScan offers:
- A broader field of view, reducing sampling error.
- Noninvasive, quick, and repeatable measurements.
Limit: FibroScan cannot detect cellular-level changes like ballooning hepatocytes or subtle inflammation. In practice, FibroScan is often used as a rule-out tool—very low stiffness values make advanced fibrosis unlikely. Very high values, by contrast, may prompt closer monitoring or confirmatory testing.
Combining Ultrasound and FibroScan
Ultrasound and FibroScan serve complementary purposes:
- Ultrasound: Shows liver anatomy and texture.
- FibroScan: Quantifies fat and stiffness more precisely.
Clinicians often use both when evaluating MASLD, especially if lifestyle changes or medications are being considered.
What Researchers Are Still Debating
- Cutoff thresholds: Different studies propose slightly different CAP and kPa cut points, leading to variation.
- Metabolic influences: Obesity, diabetes, and insulin resistance may affect readings in ways not fully understood.
- Long-term use: Early evidence suggests FibroScan can track improvement after weight loss or bariatric surgery, but more validation is needed.
Making Sense of Your Results
Instead of seeing CAP or stiffness as a pass/fail, view them as markers along a continuum. One test alone cannot define liver health. Context is key:
- Blood work: ALT, AST, GGT trends.
- Metabolic markers: A1c, triglycerides, waist circumference.
- Lifestyle factors: Diet, sleep, alcohol, physical activity.
FibroScan can serve as a guide, but it only becomes meaningful when paired with lab results, imaging, and medical history to provide full direction.
What You Can Do If Scores Are Elevated
If your numbers are higher than expected, research suggests several supportive strategies—always individualized with professional guidance:
- Weight management: A reduction of 5–10% of body weight can improve liver fat and sometimes stiffness.
- Balanced nutrition: Mediterranean-style eating patterns support better liver markers; minimizing ultra-processed foods may help.
- Movement: Aerobic and resistance training may reduce liver fat even without weight loss.
- Alcohol moderation: Even small amounts can contribute to fat buildup in some people.
- Manage comorbidities: Keeping blood sugar, cholesterol, and blood pressure under control improves long-term outcomes.
Safety note: Extreme fasting, restrictive diets, or unsupervised supplements are not recommended without clinical supervision.
FAQs
Q: What does a CAP score mean on FibroScan?
A: CAP reflects fat in the liver, measured in decibels per meter. Higher values generally indicate more fat. Around 238–260 dB/m suggests mild steatosis, while ≥~291 dB/m suggests severe fat.
Q: What is a normal FibroScan stiffness score?
A: Typically, <~6 kPa indicates low likelihood of significant fibrosis. Values >~12–15 kPa are often associated with advanced fibrosis or cirrhosis, though results must be interpreted with context.
Q: Can food or exercise affect my FibroScan?
A: Yes. Eating before the test may raise stiffness, and CAP may decrease. Strenuous exercise beforehand can also influence readings. Fasting at least 3 hours is recommended.
Q: Is FibroScan better than ultrasound?
A: They serve different purposes. Ultrasound shows structure, while FibroScan quantifies fat and stiffness. Many clinics use both together.
Q: Can FibroScan track improvement if I lose weight?
A: Sometimes. CAP and stiffness scores may decline after weight loss or lifestyle change, but results vary. Repeating the test under consistent conditions is key for tracking.
